venlafaxine hydrochloride has been researched along with Cardiotoxicity in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, MIM; Ali, SM; Arafat, HEK; Imbaby, S; Kolieb, E; Maher, SA | 1 |
| Braganca, C; Cetran, L; Goncalves, R; Hertzog, T; Labadie, M | 1 |
| Bauersachs, J; Haverich, A; Kühn, C; Napp, LC; Schäfer, A; Tongers, J; Vogel-Claussen, J | 1 |
| Capron, A; Castanares-Zapatero, D; Gillard, N; Hantson, P; Haufroid, V | 1 |
4 other study(ies) available for venlafaxine hydrochloride and Cardiotoxicity
| Article | Year |
|---|---|
Cardioprotective and renoprotective effects of venlafaxine on cisplatin-induced cardiotoxicity and nephrotoxicity in rats.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Cardiotoxicity; Cisplatin; Kidney; Oxidative Stress; Rats; Venlafaxine Hydrochloride | 2023 |
Delayed cardiotoxicity in venlafaxine and quetiapine overdose.
Topics: Antipsychotic Agents; Cardiotoxicity; Cyclohexanols; Dibenzothiazepines; Drug Overdose; Humans; Quetiapine Fumarate; Venlafaxine Hydrochloride | 2021 |
First-in-Man Fully Percutaneous Complete Bypass of Heart and Lung.
Topics: Antidepressive Agents, Second-Generation; Cardiac Rehabilitation; Cardiotoxicity; Extracorporeal Membrane Oxygenation; Heart Arrest; Heart-Assist Devices; Humans; Male; Recovery of Function; Shock, Cardiogenic; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Ventricular Function, Left; Ventricular Function, Right; Young Adult | 2017 |
Reversible cardiac dysfunction after venlafaxine overdose and possible influence of genotype and metabolism.
Topics: Antidepressive Agents, Second-Generation; Cardiotoxicity; Cytochrome P-450 CYP2D6; Depression; Drug Overdose; Female; Genotype; Humans; Middle Aged; Suicide, Attempted; Venlafaxine Hydrochloride | 2016 |